OTCPK:MEDVF - Post by User
Post by
Sarb99on Aug 19, 2020 1:01pm
129 Views
Post# 31429200
Spectral Analytics seems much more than Covid-19 drug trial
Spectral Analytics seems much more than Covid-19 drug trialhttps://www.scientificfederation.com/medicinal-chemistry-2019/program.php Abstract This disquisition is designed to be an exploration of the controversies, contentions, and consternations with regard to the efficacy and potential of a newly devised CAM approach which entails modulating the endocannabinoid system and is considered to be a potentially useful technique for the treatment of obesity and diabetes. This paper is constructed to provide the reader with an understanding of the principles underlying a form of Complimentary Alternative Medicine (CAM) which has existed for millennia but has only recently attained credibility and acceptance within the scientific community. It provides a historical analysis of the perceived equivalency between synthetic cannabinoids and biologic cannabinoids as well as the unknowns of each in their potential treatment of obesity and diabetes.
Biography David A Dawson is completing his PhD specializing in Biomolecular Psychology from Northcentral University and currently serves as Chief Science Officer for Spectral Analytics Inc. He has published two books and numerous papers in reputed journals focusing on phytocannabinoid supplementation for a variety of endocannabinoid deficiency disorders.
David A. Dawson / Northcentral University